The UC-MSC-treated group showed a decreasing trend in fasting and postprandial C-peptide.
← all excerpts
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies.
1
—
—
The UC-MSC-treated group showed a decreasing trend in fasting and postprandial C-peptide.